腾盛博药追加 1 亿&

腾盛博药追加 1 亿美元用于推进临床后期单克隆抗体联合疗法BRII-196/BRII-198用于门诊COVID-19患者的治疗-美通社PR-Newswire

腾盛博药追加 1 亿美元用于推进临床后期单克隆抗体联合疗法BRII-196/BRII-198用于门诊COVID-19患者的治疗-美通社PR-Newswire

prnasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnasia.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Sheng , Guangdong , United States , Hong Kong , , Public Health , Administration China Country , China Hong Kong Department Of Health , United States National Health Institute , Us Pass Agency China , Technology Limited Proton Sheng Or , Proton Sheng , Agency China Beijing , North Carolina City , Technology Limited , Cross Country , New Market , China Hong Kong Department , United States Country ,